U.S. Building Stock News

Flowers Foods (NYSE:FLO) announced planned retirements of longtime board member George E. Deese and director Edward J. Casey, Jr. The company expects both directors to step down at the 2026 annual meeting. At the same time, Flowers Foods plans to reduce the size of its board from 11 to 9 members. The changes are intended to streamline the company’s governance structure and board oversight. Flowers Foods, a major producer of packaged bakery foods in the US, operates in a sector where brand...

If you are wondering whether Valaris is priced attractively or already baking in a lot of optimism, you are not alone. This article focuses squarely on what you might be paying for at today's share price. The stock last closed at US$94.55, with returns of 2.2% over 7 days, 62.2% over 30 days, 81.3% year to date, and 158.1% over the past year. This naturally raises questions about how much value is left on the table versus how much risk has been added. Recent news coverage around offshore...

HealthEquity (HQY) has been drawing attention after recent share price moves, with the stock down about 7% over the past month and roughly 26% over the past 3 months. See our latest analysis for HealthEquity. Zooming out, HealthEquity’s recent weakness, including a 6.78% 30 day share price return decline and a 26.42% 90 day share price return decline, sits alongside a 27.67% 1 year total shareholder return decline. This suggests momentum has been fading after earlier multi year gains. If this...

DiamondRock Hospitality (NasdaqGS:DRH) has announced the retirement of founding Chairman and inaugural CEO William W. McCarten after more than 20 years with the company. Bruce D. Wardinski has been appointed as the new non executive Chairman, marking a shift in board leadership. The company is also reducing the size of its board, signaling a change in its governance structure. For shareholders watching DiamondRock Hospitality at a share price of $10.33, this leadership handover comes after...

If you are wondering whether Martin Marietta Materials shares still offer value after a strong run, this article will walk through what the current price might be implying about the company. The stock recently closed at US$678.46, with returns of 0.5% over 7 days, 4.5% over 30 days, 6.9% year to date, 41.5% over 1 year, 90.0% over 3 years and 111.9% over 5 years. This naturally raises questions about what is already priced in. Recent news coverage has focused on Martin Marietta Materials as...

UGI Utilities, a subsidiary of NYSE:UGI, has begun major infrastructure upgrades in Lancaster, Pennsylvania, focused on gas system safety and reliability. The Pennsylvania Public Utility Commission has opened a formal investigation into UGI Utilities' proposed natural gas rate changes affecting nearly 690,000 customers statewide. These developments center on long term service quality, customer bills, and how UGI balances investment needs with regulatory oversight. UGI, through UGI...

Corpay (NYSE:CPAY) has entered into and extended several multi year partnerships across global sports. The company will serve as an official corporate foreign exchange and payments provider for LIV Golf, Rugby Australia, and Pramac Racing. These agreements broaden Corpay's presence across golf, rugby, and motorsport with long term visibility across multiple regions. Corpay, trading at around $334.12, has had mixed share performance, with an 11.2% gain year to date and a 57.2% return over 3...

DigitalBridge Group (DBRG) closed out FY 2025 with fourth quarter revenue of US$47.9 million and basic EPS of US$0.26, while trailing twelve month basic EPS stood at US$0.48 on revenue of US$94.0 million, alongside a reported 93.2% net margin that includes the impact of a large one off loss earlier in the year. The company has seen quarterly revenue move between US$3.8 million and US$47.9 million over the past four quarters while basic EPS ranged from US$0.02 to US$0.26, giving investors a...

Axon Enterprise (AXON) closed out FY 2025 with Q4 revenue of US$796.7 million and basic EPS of US$0.03, alongside trailing twelve month revenue of US$2.8 billion and EPS of US$1.60 that sit against a net profit margin of 4.5% versus 18.1% a year earlier. The company has seen revenue move from US$575.1 million in Q4 2024 to US$796.7 million in Q4 2025, while quarterly basic EPS shifted from US$1.77 to US$0.03 over the same period, with a US$107.5 million one off gain influencing the trailing...

If you are wondering whether Cohen & Steers is attractively priced right now, this article walks through what the current share price may or may not be reflecting about its underlying value. The stock last closed at US$67.14, with returns of 0.4% over 7 days, 3.1% over 30 days, 5.6% year to date, 4.1% over 3 years and 22.0% over 5 years, alongside a 19.7% decline over the past year that some investors may see as a reset in expectations. Recent news coverage has focused on Cohen & Steers as a...

Safety Insurance Group (SAFT) has wrapped up FY 2025 with Q4 revenue of US$319.3 million and basic EPS of US$1.37, rounding out a year in which trailing twelve month revenue reached about US$1.26 billion and EPS came in at US$6.75. Over recent quarters, the company has seen revenue move from US$286.7 million and EPS of US$0.55 in Q4 2024 to the latest Q4 2025 levels. The trailing net profit margin of 7.9% sits above the 6.3% recorded a year earlier, setting up a results season where higher...

Globe Life (GL) has raised its quarterly dividend to US$0.33 per share and set payment for May 1, 2026. The company has also added Derek T. Kan and Sandra L. Phillips to its board. See our latest analysis for Globe Life. At a share price of US$146.08, Globe Life has seen a 6.33% 30 day share price return and an 8.42% 90 day share price return. Its 1 year total shareholder return of 18.60% suggests recent momentum has added to longer term gains, with the dividend increase and board refresh...

Salesforce FY 2026 earnings snapshot Salesforce (CRM) has just wrapped up FY 2026 with Q4 revenue of US$11.2b and basic EPS of US$2.08, setting the tone for a year where investors are watching how top line scale and per share profitability move together. The company has seen quarterly revenue move from US$9.8b in Q1 FY 2026 to US$11.2b in Q4, with basic EPS ranging from US$1.61 to US$2.20 over the same stretch. Trailing 12 month revenue reached US$41.5b and EPS came in at US$7.85. Taken...

If you are wondering whether Huron Consulting Group shares are attractively priced or asking too much, you are in the right place for a clear look at value. The stock most recently closed at US$143.29, with returns of 9.4% over 7 days, a 15.7% decline over 30 days, a 16.2% decline year to date, and a 4.2% decline over 1 year, set against a 73.0% return over 3 years and 174.7% over 5 years. Recent news around Huron has focused on its role as a consulting partner helping organizations handle...

In February 2026, Larimar Therapeutics announced that the FDA granted Breakthrough Therapy Designation to nomlabofusp for treating adults and children with Friedreich’s ataxia, while the company advanced plans for an accelerated Biologics License Application supported by skin frataxin as a novel surrogate endpoint. This combination of expedited regulatory status and FDA alignment on using a new biomarker underscores how central nomlabofusp has become to Larimar’s clinical and regulatory...

Vaxart (VXRT) is drawing fresh attention ahead of its scheduled presentation at the Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 25, 2026. Investors will be listening for pipeline and funding updates. See our latest analysis for Vaxart. Vaxart’s recent 34.83% 7 day share price return and 102.97% 90 day share price return point to building momentum ahead of the conference, even as the 5 year total shareholder return of 87.31% highlights longer term challenges. If...

If you are wondering whether HA Sustainable Infrastructure Capital is priced fairly today, you are not alone. This article is designed to help you weigh up what you are really paying for. The stock recently closed at US$36.85, with returns of 7.2% over 30 days, 15.8% year to date, 36.9% over 1 year and 41.9% over 3 years, while the 5 year return sits at an 11.4% decline. These figures can change how investors think about both upside potential and risk. Recent news around the broader...

MercadoLibre FY 2025 earnings snapshot MercadoLibre (MELI) has wrapped up FY 2025 with fourth quarter revenue of US$8.8b and basic EPS of US$11.03, alongside net income of US$559m, putting fresh numbers behind the recent share price of US$1,740.88. The company has seen quarterly revenue move from US$6.1b and EPS of US$12.60 in Q4 2024 to US$8.8b and EPS of US$11.03 in Q4 2025, while trailing twelve month EPS sits at US$39.39 on revenue of US$28.9b. This gives investors a basis to weigh high...

PicS N.V. completed a US$434.3 million initial public offering. The company began trading on the Nasdaq Global Select Market under the ticker NasdaqGS:PICS. This is the first new stock listing by a Brazilian company in over four years. With its IPO now complete, PicS enters the public markets at a share price of $17.76 and a recent 7 day return of 17.6%. The listing of NasdaqGS:PICS also marks a return of Brazilian issuers to international equity markets after a multi year pause in new...

International General Insurance Holdings (IGIC) has put income front and center by declaring an extraordinary cash dividend of $1.15 per share, payable on April 6, 2026, to shareholders of record on March 18. See our latest analysis for International General Insurance Holdings. The extraordinary and ordinary dividends, along with the recently completed US$8.09 million buyback, come after a period where the share price has moved steadily rather than sharply. The 30 day share price return is...

Terns Pharmaceuticals (TERN) has drawn attention after recent trading, with the stock closing at US$40.92. For investors, the clinical stage focus on oncology and obesity raises questions about how current pricing reflects trial progress and cash needs. See our latest analysis for Terns Pharmaceuticals. While the share price slipped around 1% on the day to US$40.92, it remains on a strong short term run, with a 16.61% 1 month share price return and a 45.57% 3 month share price return,...

LifeStance Health Group (LFST) capped FY 2025 with fourth quarter revenue of US$382.2 million and basic EPS of US$0.03, while trailing twelve month revenue reached about US$1.4 billion with basic EPS of US$0.03. The company has seen revenue move from US$325.5 million in Q4 FY 2024 to US$382.2 million in Q4 FY 2025, alongside a shift in quarterly basic EPS from a loss of US$0.02 to a profit of US$0.03. This places improving profitability metrics at the center of the current earnings...

Crescent Energy (CRGY) closed FY 2025 with fourth quarter revenue of US$865.0 million and a small net loss of US$8.7 million, which translated into EPS of US$0.03 loss per share, while trailing 12 month revenue stood at about US$3.6 billion with net income of US$132.9 million and EPS of US$0.51. Over recent periods, revenue has ranged from US$744.9 million to US$950.2 million a quarter, with quarterly EPS swinging between a US$0.70 loss and a US$0.61 profit, so the latest numbers land in the...

If you are trying to work out whether Cactus is attractively priced or not, the stock's recent moves and current valuation metrics give you quite a bit to think about. Cactus closed at US$51.56, with returns of 9.6% year to date, a 12.3% decline over the past week and an 8.7% decline over the past month, while the 1 year return sits at 0.2% and the 5 year return at 56.2%. These mixed short term moves against a relatively stronger multi year return profile set the backdrop for investors...